Reviews
Klin Onkol 1989; 2(5): 131-132.
Authors: Kopečný J.1989-10-15:Analysis of treatment results by cervix uteri carcinoma
Authors: Kopečný J.1989-10-15:Analysis of treatment results by cervix uteri carcinoma
Klin Onkol 1989; 2(5): 133-140.
Authors: Jurga Ľudovít, Matula Pavol1989-10-15:Clinical aspects of the use of modificated fractionation of radiotherapy by combination of radiotherapy and chemotherapy
Authors: Jurga Ľudovít, Matula Pavol1989-10-15:Clinical aspects of the use of modificated fractionation of radiotherapy by combination of radiotherapy and chemotherapy
Original articles
Klin Onkol 1989; 2(5): 141-148.
Authors: Tačev T., Michálek Jaroslav, Polách J., Prokeš B., Strnad V., Rašovská O., Kryštof V.1989-10-15:Monitoring of regression in the uterine cervix in the course of radiotherapy
Authors: Tačev T., Michálek Jaroslav, Polách J., Prokeš B., Strnad V., Rašovská O., Kryštof V.1989-10-15:Monitoring of regression in the uterine cervix in the course of radiotherapy
Klin Onkol 1989; 2(5): 149-151.
Authors: Strnad V.1989-10-15:Colorectal cencer - to-date indications and results of radiotherapy
Authors: Strnad V.1989-10-15:Colorectal cencer - to-date indications and results of radiotherapy
Klin Onkol 1989; 2(5): 152-156.
Keywords: non-Hodgkin lymphoma, translocation, childhood
Authors: Stejskalová E., Weinreb Michal, Goetz Petr1989-10-15:Possibilities of the cytogenetic egvaluation of childhood malignant lymphoma
Keywords: non-Hodgkin lymphoma, translocation, childhood
Authors: Stejskalová E., Weinreb Michal, Goetz Petr1989-10-15:Possibilities of the cytogenetic egvaluation of childhood malignant lymphoma
Report
Klin Onkol 1989; 2(5): 157.
Authors: J.D. J.D., Wagstaff J., Gregory W.M., Swindell R., Crowther D., Lister Thomas Andrew 1989-10-15:The Prognostic Factors and Survival in Patients with Stages III.B and IV. Hodgkins Disease
Authors: J.D. J.D., Wagstaff J., Gregory W.M., Swindell R., Crowther D., Lister Thomas Andrew 1989-10-15:The Prognostic Factors and Survival in Patients with Stages III.B and IV. Hodgkins Disease
Klin Onkol 1989; 2(5): 157.
Authors: J.D. J.D., Zulian G.B., Selby P., Milan S.1989-10-15:High dose Melphalan, BCNU, and Etoposide with autologous bone marrow transplantation for Hodgkin´s disease
Authors: J.D. J.D., Zulian G.B., Selby P., Milan S.1989-10-15:High dose Melphalan, BCNU, and Etoposide with autologous bone marrow transplantation for Hodgkin´s disease
Klin Onkol 1989; 2(5): 158.
Authors: J.D. J.D., Teerenhovi L., Lindholm C., Pakkala A., Franssila K., Stein Harald, Knuutila S.1989-10-15:Unique display of a pathologic karyotype in Hodgkin disease by Reed-Sternberg cell
Authors: J.D. J.D., Teerenhovi L., Lindholm C., Pakkala A., Franssila K., Stein Harald, Knuutila S.1989-10-15:Unique display of a pathologic karyotype in Hodgkin disease by Reed-Sternberg cell
Klin Onkol 1989; 2(5): 158.
Authors: J.D. J.D., De La Gruz C.A., Cardenes H., Otero J.1989-10-15:Individual risk of abdominal disease in patients with stages I and II supradiaphragmatic Hodgkin´s disease
Authors: J.D. J.D., De La Gruz C.A., Cardenes H., Otero J.1989-10-15:Individual risk of abdominal disease in patients with stages I and II supradiaphragmatic Hodgkin´s disease
Information
Klin Onkol 1989; 2(5): 159-160.
Keywords: review
1989-10-15:review: Regional cancer treatment
Keywords: review
1989-10-15:review: Regional cancer treatment
Klin Onkol 1989; 2(5): 160.
1989-10-15:Symposium
1989-10-15:Symposium